Human parvovirus B19 infection in pregnancy: Should screening be offered to the low-risk population?

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 42, Issue 4, 2002, Pages 347-351

  Wong, Shell Fean ^a   Chan, Fung Yee ^a   Cincotta, Robert B ^a   Tilse, Martin ^a  

^a MATER MOTHERS HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS VACCINE;

ERYTHEMA INFECTIOSUM; FEMALE; FETUS DEATH; FETUS HYDROPS; FETUS OUTCOME; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; PARVOVIRUS; PERINATAL DEATH; POPULATION RESEARCH; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING TEST;

EID: 0036818088     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0004-8666.2002.00347.x     Document Type: Review

References (51)

1. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL, Cohen BJ, Mortimer PP, Pereira MS. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet. 1983 Jun 18; 1 (8338):1378.
2. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med. 1987 Jan 22; 316 (4): 183-186.
3. Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984 Nov 3; 2 (8410): 1033-1034.
4. Rodis JF, Hovick TJ Jr, Quinn DL, Rosengren SS, Tattersall P. Human parvovirus infection in pregnancy. Obstet Gynecol. 1988 Nov; 72 (5): 733-738.
5. Rodis JF, Quinn DL, Gary GW Jr, Anderson LJ, Rosengren S, Cartter ML, Campbell WA, Vintzileos AM. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol. 1990 Oct; 163 (4 Pt 1): 1168-1171.
6. Gratacos E, Torres PJ, Vidal J, Antolin E, Costa J, Jimenez de Anta MT, Cararach V, Alonso PL, Fortuny A. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis. 1995 May; 171 (5): 1360-1363.
7. Porter HJ, Khong TY, Evans MF, Chan VT, Fleming KA. Parvovirus as a cause of hydrops fetalis: detection by in situ DNA hybridisation. J Clin Pathol. 1988 Apr; 41 (4): 381-383.
8. Yaegashi N, Okamura K, Yajima A, Murai C, Sugamura K. The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis. J Perinat Med. 1994; 22 (2): 159-163.
9. Heinonen S, Ryynanen M, Kirkinen P. Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet Gynecol Scand. 2000 Jan; 79 (1): 15-18.
10. Machin GA. Hydrops revisited: literature review of 1,414 cases published in the 1980s. Am J Med Genet. 1989 Nov; 34 (3): 366-390.
11. Skjoldebrand-Sparre L, Tolfvenstam T, Papadogiannakis N, Wahren B, Broliden K, Nyman M. Parvovirus B19 infection: association with third-trimester intrauterine fetal death. BJOG. 2000 Apr; 107 (4): 476-480.
12. Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol. 1998 Mar; 91 (3): 413-420.
13. Fairley CK, Smoleniec JS, Caul OE, Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet. 1995 Nov 18; 346 (8986): 1335-1337.
14. Rodis JF, Borgida. AF, Wilson M, Egan JF, Leo MV, Odibo AO, Campbell WA. Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol. 1998 Oct; 179 (4): 985-988.
15. Carlsen KM. Human parvovirus B19. Biotrin International Ltd publication, 1996.
16. Morbidity and Mortality Weekly Report: Risks associated with human parvovirus B19 infections. MMWR, 1989; 38: 81-87.
17. Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B 19 during pregnancy: a review. Obstet Gynecol Surv. 1997 Apr; 52 (4): 254-259.
18. Brown KE, Green SW, Antunez de Mayolo J, Bellanti JA, Smith SD, Smith TJ, Young NS. Congenital anaemia after transplacental B19 parvovirus infection. Lancet. 1994 Apr 9; 343 (8902): 895-896.
19. Brown KE, Young NS. Parvovirus B19 in human disease. Annu Rev Med. 1997; 48: 59-67.
20. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol. 1988 Feb; 25 (2):151-153.
21. Guidozzi F, Ballot D, Rothberg AD. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome. J Reprod Med. 1994 Jan; 39 (1): 36-38.
22. Valeur-Jensen AK, Pedersen CB, Westergaard T, Jensen IP, Lebech M, Andersen PK, Aaby P, Pedersen BN, Melbye M. Risk factors for parvovirus B19 infection in pregnancy. JAMA. 1999 Mar 24-31; 281 (12): 1099-1105.
23. Karunajeewa H, Siebert D, Hammond R, Garland S, Kelly H. Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management. Aust N Z J Obstet Gynaecol. 2001 Feb; 41 (1): 23-28.
24. Jensen IP, Thorsen P, Jeune B, Moller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG. 2000 May; 107 (5): 637-643.
25. Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. BMJ. 1990 May 5; 300 (6733):1166-1170.
26. Hall SM, Cohen BJ, Mortimer PP, Caul EO, Cradock-Watson J. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J. 1990 May 5; 300: 1166-1170.
27. Schwarz TF, Roggendorf M, Hottentrager B, Deinhardt F, Enders G, Gloning KP, Schramm T, Hansmann M. Human parvovirus B19 infection in pregnancy. Lancet. 1988 Sep 3; 2 (8610): 566-567.
28. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998 Feb; 105 (2): 174-178.
29. Schild RL, Bald R, Plath H, Eis-Hubinger AM, Enders G, Hansmann M. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol. 1999 Mar; 13 (3): 161-166.
30. Smulian JC, Egan JF, Rodis JF. Fetal hydrops in the first trimester associated with maternal parvovirus infection. J Clin Utrasound. 1998 Jul-Aug; 26 (6): 314-316.
31. Weiland HT, Vermey-Keers C, Salimans MM, Fleuren GJ, Verwey RA, Anderson MJ. Parvovirus B19 associated with fetal abnormality. Lancet. 1987 Mar 21; 1 (8534): 682-683.
32. Naides SJ, Weiner CP. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn. 1989 Feb; 9 (2): 105-114.
33. Yaegashi N. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J Exp Med. 2000 Feb; 190 (2): 65-82.
34. Kyriazopoulou V, Simitsopoulou M, Bondis J, Diza E, Athanasiadis A, Frantzidou F, Souliou E. Human parvovirus B19: immunity of Greek females and prenatal investigation of hydrops fetalis. Eur J Obstet Gynecol Reprod Biol. 1997 Aug; 74 (2): 157-160.
35. Bond PR, Caul EO, Usher J, Cohen BJ, Clewley JP, Field AM. Intrauterine infection with human parvovirus. Lancet. 1986 Feb 22; 1 (8478): 448-449.
36. Morey AL, Keeling JW, Porter HJ, Fleming KA. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol. 1992 Jul; 99 (7): 566-574.
37. Gillespie SM, Cartter ML, Asch S, Rokos JB, Gary GW, Tsou CJ, Hall DB, Anderson LJ, Hurwitz ES. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA. 1990 Apr 18; 263 (15): 2061-2065.
38. Rugolotto S, Padovani EM, Sanna A, Chiaffoni GP, Marradi PL, Borgna-Pignatti C. Intrauterine anemia due to parvovirus B19: successful treatment with intravenous immunoglobulins. Haematologica. 1999 Jul; 84 (7): 668-669.
39. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989 Aug 24; 321 (8): 519-523.
40. Ramage JK, Hale A, Gane E, Cohen B, Boyle M, Mufti G, Williams R. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin. Lancet. 1994 Mar 12; 343 (8898): 667-668.
41. Bansal GP, Hatfield JA, Dunn FE, Kramer AA, Brady F, Riggin CH, Collett MS, Yoshimoto K, Kajigaya S, Young NS. Candidate recombinant vaccine for human B19. J Infect Dis. 1993 May; 167 (5): 1034-1044.
42. Anderson S, Momoeda M, Kawase M, Kajigaya S, Young NS. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology. 1995 Jan 10; 206 (1): 626-632.
43. Bostic JR, Brown KE, Young NS, Koenig S. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay. J Infect Dis. 1999 Mar; 179 (3): 619-626.
44. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, Dorman KF, Ludomirsky A, Gonzalez R, Gomez R, Oz U, Detti L, Copel JA, Bahado-Singh R, Berry S, Martinez-Poyer J, Blackwell SC. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 2000 Jan 6; 342 (1):9-14.
45. Abdel-Fattah SA, Soothill PW, Carroll SG, Kyle PM. Noninvasive diagnosis of anemia in hydrops fetalis with the use of middle cerebral artery Doppler velocity. Am J Obstet Gynecol. 2001 Dec; 185 (6): 1411-1415.
46. Delle Chiaie L, Buck G, Grab D, Terinde R. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection. Ultrasound Obstet Gynecol. 2001 Sep; 18 (3): 232-236.
47. Stefos T, Cosmi E, Detti L, Mari G. Correction of fetal anemia on the middle cerebral artery peak systolic velocity. Obstet Gynecol. 2002 Feb; 99 (2): 211-215.
48. von Kaisenberg CS, Bender G, Scheewe J, Hirt SW, Lange M, Stieh J, Kramer HH, Jonat W. A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation. Fetal Diagn Ther. 2001 Nov-Dec; 16 (6): 427-432.
49. Tongsong T, Wanapirak C, Sirichotiyakul S, Piyamongkol W, Chanprapaph P. Fetal sonographic cardiothoracic ratio at mid-pregnancy as a predictor of Hb Bart disease. J Ultrasound Med. 1999 Dec; 18 (12): 807-811.
50. Kailasam C, Brennand J, Cameron AD. Congenital parvovirus B19 infection: experience of a recent epidemic. Fetal Diagn Ther. 2001 Jan-Feb; 16 (1): 18-22.
51. Vogel H, Kornman M, Ledet SC, Rajagopalan L, Taber L, McClain K. Congenital parvovirus infection. Pediatr Pathol Lab Med. 1997 Nov-Dec; 17 (6): 903-912.